From WikiProjectMedJump to navigation Jump to search
|NY (what is this?)|
Phase II clinical trial evaluating the treatment of breast cancer was terminated due to change in Fresenius' development plans. (So they could concentrate on their other product catumaxomab (trade name Removab).: 35 )
Retrieved from "https://mdwiki.org/wiki/Ertumaxomab"